Dataset Information

De novo headache in ischemic stroke patients treated with thrombectomy: a prospective study.

ABSTRACT:

Background and aim

Headache attributed to intracranial endovascular procedures is described in the ICHD-3. Our aim was to study the frequency and characteristics of headache specifically related to thrombectomy in patients with ischemic stroke.

Methods

Prospective evaluation of clinical features of headache after thrombectomy using an ad hoc questionnaire.

Results

One hundred seventeen patients were included (52.1% females). Most had an anterior circulation artery occlusion (91.5%). 93 (79.5%) received general anaesthesia. 111 (94.9%) required stent retriever, 21 (24.4%) angioplasty and 19 (16.2%) aspiration thrombectomy. 31 (26.5%; 95% CI 18.8-35.5%) had headache related to thrombectomy, and it was associated with a history of primary headache (p = 0.004). No differences about sex, initial NIHSS score, or the type or complexity of the procedure were observed. Headache was usually moderate and oppressive, ipsilateral to the artery occlusion and usually lasted less than 48 hours.

Conclusions

Almost one-third of patients with ischemic stroke who undergo endovascular thrombectomy experience headache in the first 24 hours, occurring more frequently in patients who had a previous history of headaches regardless of the procedure complexity.

SUBMITTER: Gallo D

PROVIDER: S-EPMC9306161 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

De novo headache in ischemic stroke patients treated with thrombectomy: a prospective study.

Gallo Daniel D Manrique Leire L Polanco Marcos M González-Mandly Andrés A Torres Eduardo E Palacio Enrique E Vázquez José Luis JL Pérez-Pereda Sara S González-Quintanilla Vicente V Madera Jorge J Pascual Julio J

The journal of headache and pain 20220721 1

<h4>Background and aim</h4>Headache attributed to intracranial endovascular procedures is described in the ICHD-3. Our aim was to study the frequency and characteristics of headache specifically related to thrombectomy in patients with ischemic stroke.<h4>Methods</h4>Prospective evaluation of clinical features of headache after thrombectomy using an ad hoc questionnaire.<h4>Results</h4>One hundred seventeen patients were included (52.1% females). Most had an anterior circulation artery occlusion ...[more]

PMID: 35864440

Similar Datasets

Project description:Introduction:Limited comparative studies have reported the safety and efficacy of tirofiban in acute ischemic stroke (AIS) patients after mechanical thrombectomy (MT). Additionally, the available studies are inconsistent with each other, which makes application of tirofiban unclear in neuro-intervention. Here, we performed a comparative retrospective study to investigate whether tirofiban combined with MT improves short- and long-term prognosis in AIS patients and whether its use is associated with complications. Method:Retrospective data were collected for AIS patients admitted between January 2013 and January 2019 at three stroke centers. According to whether tirofiban was used during the operation, patients were divided into tirofiban group and control group. Multivariate and COX regression analyses were performed to determine the association of tirofiban treatment with safety and efficiency in subjects treated with MT. Result:A total of 174 patients were analyzed, of whom 89 (51.1%) were treated with tirofiban. There were no differences in the incidence of symptomatic intracerebral hemorrhage (10.2% vs. 10.6%, p=0.918), parenchymal hemorrhage type 2 (18.0% vs. 16.5%, p=0.793), and reocclusion at 24?h (3.4% vs. 10.6%, p=0.060) between the tirofiban group and control group. Multivariate regression showed that tirofiban was not associated with intracerebral hemorrhage, early neurological deterioration, neurological improvement at 7 days, functional independence at 3-month and 9-month follow-up, or death at 9-month follow-up (adjusted p > 0.05 for all). However, AIS patients treated with MT?+?tirofiban showed a trend towards acquiring faster functional independence, with a median time to acquire functional independence of 4.0 months compared with 6.5 months in the control group (risk ratio?=?1.49, 95% confidence interval 0.98-2.27; long rank p=0.066). Conclusion:Tirofiban may help AIS patients given MT to gain functional independence faster, without increasing the risk of complications.

Dataset Information

De novo headache in ischemic stroke patients treated with thrombectomy: a prospective study.

Background and aim

Methods

Results

Conclusions

Publications

De novo headache in ischemic stroke patients treated with thrombectomy: a prospective study.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets